Previous 10 | Next 10 |
home / stock / prn:cc / prn:cc news
2023-09-07 02:37:54 ET Profound Medical ( NASDAQ: PROF ) announced an at-the-market equity program that allows the company, through certain securities dealers acting as agents, to issue and sell from time to time up to $30M of shares. The timing and extent of the us...
TORONTO, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“ Profound ” or the “ Company ”) announces that it has established an at-the-market equity program (the “ ATM Program ”) that allows the Company, thro...
2023-08-09 23:08:14 ET Profound Medical Corp. (PROF) Q2 2023 Earnings Conference Call August 09, 2023, 04:30 PM ET Company Participants Stephen Kilmer - IR Arun Menawat - CEO Rashed Dewan - CFO Conference Call Participants Rahul Sarugaser - Raymond Ja...
2023-08-09 16:57:33 ET Profound Medical press release ( NASDAQ: PROF ): Q2 GAAP EPS of $0.35 beats by $0.70 . Revenue of $1.61M (-19.5% Y/Y) misses by $0.51M . For further details see: Profound Medical GAAP EPS of $0.35 beats by $0.70, revenue of $1.61M m...
TORONTO, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue...
TORONTO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, wi...
2023-07-14 16:23:57 ET Summary EDAP TMS S.A. shares have pushed lower in H2 FY'23, presenting an opportunity to add on weakness. EDAP's Q1 revenues were up 13.8% YoY, with HIFU sales up around 40% YoY. On examination, sentiment and positioning remains bullish in the stock base...
2023-06-22 05:10:19 ET Summary Profound Medical Corp's TULSA-PRO system has the potential to disrupt the surgical treatment of prostate disease. The company is delivering solid growth in recurring and capital revenues. Despite high market multiples, the company's forecasted gr...
TORONTO, June 02, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, an...
TORONTO, May 30, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, ann...
News, Short Squeeze, Breakout and More Instantly...
Profound Medical Corp. Company Name:
PRN:CC Stock Symbol:
TSXC Market:
Profound Medical Corp. Website:
TORONTO, July 11, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today ...
TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) is pleased to announce the voting results from its Annual General Meeting of Shareholders that was held today (the “Meeting”). A total ...
PROFOUND MEDICAL ANNUAL GENERAL MEETING OF SHAREHOLDERS VOTING RESULTS Canada NewsWire TORONTO , May 15, 2024 /CNW/ - Profound Medical Corp. (TSX: PRN) (NASDAQ: PROF) ("Profound" or the "Company") is pleased to announce the voting results from its Annual General ...